Large Scale AAV For Preclinical Gene Therapy Studies

UMMS and Cytiva collaboration to manufacture GLP grade viral vector suitable for primate studies

Your gene therapy candidate deserves to be a success. To fuel preclinical studies that use adeno-associated virus (AAV) for gene delivery, you need a ready supply of high-quality vector. Good laboratory practices (GLP) grade vector has the quality required for nonhuman primate studies and is a cost-effective option, because it avoids the infrastructure costs of good manufacturing practices (GMP) facilities. And the lead time to get GLP-grade vector could be much shorter.

You can get good laboratory practice (GLP)-grade vector from a new facility brought to you by Cytiva and the University of Massachusetts Medical School (UMMS). Here, you can access the combined benefits of Cytiva’s industry-leading development platforms and processing equipment plus UMMS’ professional and scientifically knowledgeable staff to help you get your research to the clinic faster.